Last Update Time:
13-Mar-2025 16:00:00
ISIN:
INE0LRU01027
Sector:
Healthcare
Symbol:
AARTIPHARM
Aarti Pharmalabs Limited
₹734.00
₹2.80
(0.38%)
▲
Prev. Close
₹731.20
Open
₹734.35
Close
₹738.95
Range
₹697.30 - ₹770.70
High
₹748.50
Low
₹726.60
Ind. Close
₹0.00
VWAP
₹742.75
The current stock price of Aarti Pharmalabs Limited is ₹734.00, with a target price range between ₹697.30 and ₹770.70. The stock has experienced a price change of ₹2.80 (0.38%), reflecting recent market volatility.
Today's opening price was ₹734.35, while the previous close stood at ₹731.20.
The market trend suggests an uptrend, making it an attractive investment opportunity for traders seeking short-term gains.
For real-time stock market updates, live share prices, and stock analysis, stay tuned. Understanding key stock metrics like VWAP, high-low range, and market momentum can help traders make informed investment decisions.
Aarti Pharmalabs Limited Price Chart
Aarti Pharmalabs Limited Pre Open Market Overview: 13-Mar-2025
Key Metrics:
- IEP (Indicative Equilibrium Price): 734.35
- Previous Close Price: 731.2
- Change: 3.15%
- Total Traded Volume: 70
- Total Buy Quantity: 9,238
- Total Sell Quantity: 5,660
| Price | Buy Qty | Sell Qty |
|---|---|---|
| 727.00 | 501.00 | 0.00 |
| 730.00 | 1,001.00 | 0.00 |
| 731.00 | 50.00 | 0.00 |
| 734.35 | 10.00 | 0.00 |
| 735.00 | 43.00 | 0.00 |
| 735.95 | 0.00 | 14.00 |
| 736.00 | 0.00 | 1.00 |
| 736.85 | 0.00 | 14.00 |
| 737.00 | 0.00 | 129.00 |
| 738.45 | 0.00 | 14.00 |
ATO Data:
- Buy Quantity (ATO): 0
- Sell Quantity (ATO): 0
Order Book
| Bid | Qty | Ask | Qty |
|---|---|---|---|
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
Total Buy Quantity: 9238
Total Sell Quantity: 5660
Shareholding Patterns of Aarti Pharmalabs Limited
Key Trade Statistics of Aarti Pharmalabs Limited
| Trade Information | Details |
|---|---|
| Traded Volume (Lakhs) | 2.69 |
| Traded Value (₹ Cr.) | 19.98 |
| Total Market Cap (₹ Cr.) | 6,651.95 |
| Free Float Market Cap (₹ Cr.) | 3,560.89 |
| Impact cost | 0.08 |
| Quantity Traded | 268,984.00 |
| Deliverable Quantity | 104,025.00 |
| % of Quantity to Traded | 38.67 |
| Security VaR | 17.62 |
| Index VaR | N/A |
| VaR Margin | 17.62 |
| Extreme Loss Rate | 3.5 |
| Adhoc Margin | N/A |
| Applicable Margin Rate | 21.12 |
| Face Value | 5 |
Key Price Statistics of Aarti Pharmalabs Limited
The 52-week high for Aarti Pharmalabs Limited was ₹837.25, recorded on 19-Feb-2025. On the other hand, the 52-week low stands at ₹399.55, with the lowest value recorded on 14-Mar-2024.
The upper band for trading is ₹877.40, and the lower band is ₹585.00. The price band is 20%.
The stock's daily volatility stands at 2.70, while the annualized volatility is 51.58. The tick size for trading is ₹0.05.
| Price Information | Details |
|---|---|
| 52 Week High (19-Feb-2025) | 837.25 |
| 52 Week Low (14-Mar-2024) | 399.55 |
| Upper Band | 877.40 |
| Lower Band | 585.00 |
| Price Band (%) | 20 |
| Daily Volatility | 2.70 |
| Annualised Volatility | 51.58 |
| Tick Size | 0.05 |
Key Securities Statistics of Aarti Pharmalabs Limited
| Securities Information | Details |
|---|---|
| Status | Listed |
| Trading Status | Active |
| Date of Listing | 30-Jan-2023 |
| Adjusted P/E | 26.86 |
| Symbol P/E | 26.86 |
| Index | NIFTY TOTAL MARKET |
| Macro-Economic Sector | Healthcare |
| Sector | Healthcare |
| Industry | Pharmaceuticals & Biotechnology |
| Basic Industry | Pharmaceuticals |
Security Status of Aarti Pharmalabs Limited
| Title | Details |
|---|---|
| Board Status | Main |
| Trading Segment | Normal Market |
| Session No. | - |
| Class of Shares | Equity |
| SDD Compliance | - |
| Name of Compliance Officer | - |
Announcements of Aarti Pharmalabs Limited
| Subject | Date |
|---|---|
| Alteration Of Capital and Fund Raising-XBRL | 10-Mar-2025 |
| ESOP/ESOS/ESPS | 10-Mar-2025 |
| Analysts/Institutional Investor Meet/Con. Call Updates | 12-Feb-2025 |
| Analysts/Institutional Investor Meet/Con. Call Updates | 07-Feb-2025 |
| Copy of Newspaper Publication | 07-Feb-2025 |
| Analysts/Institutional Investor Meet/Con. Call Updates | 06-Feb-2025 |
| Record Date | 05-Feb-2025 |
| Outcome of Board Meeting-XBRL | 05-Feb-2025 |
Corporate Actions of Aarti Pharmalabs Limited
| Face Value | Purpose | Ex-Date |
|---|---|---|
| 5 | Interim Dividend - Rs 2.50 Per Share | 14-Feb-2025 |
| 5 | Dividend - Re 1 Per Share | 31-Jul-2024 |
| 5 | Interim Dividend - Rs 2 Per Share | 16-Feb-2024 |
Board Meetings of Aarti Pharmalabs Limited
Financial Results of Aarti Pharmalabs Limited
Company Directory of Aarti Pharmalabs Limited
| Web Address | Office | Address | City |
|---|---|---|---|
| N/A | Head Office/ Corporate Office | 204, Udyog Kshetra, 2nd Floor, Mulund Goregaon Link Road, Mulund West, Mumbai 400080, |
MUMBAI |
| N/A | Registered Office | Plot No 22/C/1 & 22/C/2, 1st Phase, GIDC Vapi-396195, Valsad, Gujarat |
VAPI |
| N/A | Transfer Agent | C-101, 247 Park, LBS Marg, Vikhroli West Mumbai |
MUMBAI |
Insider Trading of Aarti Pharmalabs Limited
| Reg. Clause | Acq./Disp. | Sec. Value | Txn Type |
|---|---|---|---|
| 7(2) | Orchid Family Trust | 40568783 | Sell |
| 7(2) | Tulip Family Trust | 45202564 | Sell |
| 7(2) | Anushakti Enterprises Pvt Limited | 14865779 | Buy |
| 7(2) | Narendra J Salvi | 5773949 | Sell |
| 7(2) | MANOMAYA BUSINESS TRUST (Alabhya Trusteeship Private Limited) | 71079603 | Buy |
| 7(2) | MANOMAYA BUSINESS TRUST (Alabhya Trusteeship Private Limited) | 70563241 | Buy |
| 7(2) | Labdhi Business Trust (Saswat Trusteeship Private Limited) | 4768488 | Buy |
| 7(2) | Labdhi Business Trust (Saswat Trusteeship Private Limited) | 65393228 | Buy |
| 7(2) | Labdhi Business Trust (Saswat Trusteeship Private Limited) | 21821 | Buy |
| 7(2) | Labdhi Business Trust (Saswat Trusteeship Private Limited) | 49747229 | Buy |
| 7(2) | Manjula Mahendra Sangoi | 2480808 | Buy |
| 7(2) | Manjula Mahendra Sangoi | 2370784 | Buy |
| 7(2) | MANOMAYA BUSINESS TRUST (Alabhya Trusteeship Private Limited) | 12881746 | Buy |
| 7(2) | Labdhi Business Trust(Saswat Trusteeship Private Limited) | 20889335 | Buy |
| 7(2) | Labdhi Business Trust(Saswat Trusteeship Private Limited) | 30693509 | Buy |
| 7(2) | MANOMAYA BUSINESS TRUST (Alabhya Trusteeship Private Limited) | 30662044 | Buy |
| 7(2) | Anushakti Enterprises Pvt Limited | 116653098 | Buy |
Annual Reports of Aarti Pharmalabs Limited
| Company | From Year | To Year | Att. |
|---|---|---|---|
| Aarti Pharmalabs Limited | 2023 | 2024 | |
| Aarti Pharmalabs Limited | 2022 | 2023 |
Investor Complaints of Aarti Pharmalabs Limited
Event Calendar of Aarti Pharmalabs Limited
| Purpose | Details |
|---|---|
| Financial Results/Other business matters | To consider and approve; - Audited Financial Results for the quarter ended March 31, 2023 and Audited Financial Statements for the year ended March 31, 2023 - Any other business matter, if required, with the permission of Chair. |
| Financial Results/Other business matters | To consider and approve the financial results for the quarter ended Jun 30, 2023 and other business matters. |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended September 30, 2023 and other business matters |
| Financial Results/Dividend/Other business matters | To consider and approve the financial results for the period ended December 31, 2023, dividend and other business matters |
| Financial Results/Dividend/Other business matters | To consider and approve the financial results for the period ended March 31, 2024, dividend and other business matters |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended Jun 30, 2024 and other business matters |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended September 30, 2024 and other business matters |
| Financial Results/Dividend/Other business matters | To consider and approve the financial results for the period ended December 31, 2024, dividend and other business matters |
Share Transfers of Aarti Pharmalabs Limited
| Company | Period | Reg.7 | Reg.40 |
|---|---|---|---|
| Aarti Pharmalabs Limited | 31-MAR-2024 | ||
| Aarti Pharmalabs Limited | 31-MAR-2023 |
Voting Results of Aarti Pharmalabs Limited
| Date of Mtg. | Mtg. Type | Resolution |
|---|---|---|
| 07-AUG-2024 | AGM | To receive, consider and adopt the Audited Standalone and Consolidated Financial Statements for the financial year ended March 31, 2024 together with the Reports of the Board of Directors and Auditors￢ﾀﾙ thereon. |
| 07-AUG-2024 | AGM | Approval of the remuneration to the Cost Auditors for the Financial Year 2024-25 |
| 07-AUG-2024 | AGM | Payment of Commission to the Non-Executive Director(s) of the Company |
| 07-AUG-2024 | AGM | Appointment of Smt. Nehal Garewal (DIN: 01750146) as a Non-Executive Director of the Company |
| 07-AUG-2024 | AGM | Appointment of Shri Pradeep Thakur (DIN: 00685992) as an Independent Director of the Company |
| 07-AUG-2024 | AGM | To appoint a Director in place of Shri Rashesh C. Gogri (DIN: 00066291), who retires by rotation and being eligible, offers his candidature for re-appointment. |
| 07-AUG-2024 | AGM | To declare the final dividend @ 20% i.e. Re. 1/- (Rupee One only) per Equity share for the financial year ended March 31, 2024. |
| 14-SEP-2023 | AGM | Adoption of Annual Financial Statements |
| 14-SEP-2023 | AGM | Appointment of Shri Rajendra V. Gogri, who retires by rotation in this AGM and being eligible has offered himself for reappointment as a Director of the Company |
| 14-SEP-2023 | AGM | Appointment of Gokhale and Sathe as the Statutory Auditors of the Company. |
| 14-SEP-2023 | AGM | Approval of remuneration of the Cost Auditors for the Financial Year 2023-24 |
| 14-SEP-2023 | AGM | Approval of ￂAarti Pharma Performance Stock Option Plan 2023ￂ |
FAQs on Aarti Pharmalabs Limited
Disclaimer: The information provided here is for informational purposes only and should not be considered financial advice. Please do your own research and consult with a financial professional before making any investment decisions.